TOZINAMERAN
UNII 5085ZFP6SJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Tozinameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5085ZFP6SJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2417899-77-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5085ZFP6SJ

CAS Registry Number

2417899-77-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOZINAMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173055

National Cancer Institute reference terminology for clinical and research data.

INN ID

11889

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tozinameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOZINAMERAN

Common Names & Synonyms

PFIZER COVID-19 VACCINE

RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SECRETORY SIGNAL PEPTIDE CONTG. SPIKE GLYCOPROTEIN S1S2-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTG. POLY(A)-TAILED MESSENGER BNT162B2), INNER SALT

RNA INGREDIENT BNT-162B2

TOZINAMERAN [INN]

TOZINAMERAN [JAN]

TOZINAMERAN [WHO-DD]